Tafolecimab in Hyperlipidemia: A Study of Different Dosing Intervals
Clinical trial NCT07712042 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07712042
- Sponsor
- Mei Gao
- Status
- NOT_YET_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2026-08-01
- Primary completion
- 2028-12-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.